HKU COVID-19 vaccine trials to start in July
Share - WeChat

A COVID-19 vaccine developed by the University of Hong Kong is expected to begin human trials in July, according to He Yiwu, who leads the HKU vaccine team. However, he told China Daily on Monday that border control could slow down the vaccine manufacturing process as the city must rely on mainland manufacturers. He called for a green channel to facilitate mainland-Hong Kong collaboration in vaccine development.
- Psychologists to have a say in juvenile cases
- Digital reading trend on the rise, survey finds
- Peng calls for bolstering Sino-Kenyan relations
- Grassroots governance extends reach to win trust, address widespread issues
- Foreign trade remains robust despite protectionism, geopolitical uncertainties
- Domestic retailers give exporters boost